Reprogramming of the MHC-I and its regulation by NFκB in human-induced pluripotent stem cells

Stem Cells

Volumn 30, Issue 12, 2012, Pages 2700-2708

  Pick, Marjorie ^a,b   Ronen, Daniel ^a   Yanuka, Ofra ^a   Benvenisty, Nissim ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Immunogenicity; Induced pluripotent stem cells; Pluripotent stem cells; Reprogramming

Indexed keywords

BETA 2 MICROGLOBULIN; COMPLEMENTARY DNA; GAMMA INTERFERON; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KRUPPEL LIKE FACTOR 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; RETROVIRUS VECTOR; RNA; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTOR SOX2;

ANTIGEN EXPRESSION; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; DNA MICROARRAY; EMBRYO; EMBRYONIC STEM CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOCHEMISTRY; IMMUNOGENICITY; IMMUNOREGULATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MICROARRAY ANALYSIS; PLURIPOTENT STEM CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN FIBROBLAST; WESTERN BLOTTING;

BETA 2-MICROGLOBULIN; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELLS, CULTURED; DOWN-REGULATION; FIBROBLASTS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOCHEMISTRY; INDUCED PLURIPOTENT STEM CELLS; INTERFERON-GAMMA; MICROARRAY ANALYSIS; NF-KAPPA B; NUCLEAR REPROGRAMMING; OCTAMER TRANSCRIPTION FACTOR-3; TRANSCRIPTION FACTOR RELA;

IPS;

EID: 84870349438     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.1242     Document Type: Article

References (32)

1. Thomson JA, Itskovitz-Eldor J, Shapiro SS et al. Embryonic stem cell lines derived from human blastocysts. Science 1998;282:1145-1147.
2. Itskovitz-Eldor J, Schuldiner M, Karsenti D et al. Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers. Mol Med 2000;6:88-95.
3. Drukker M, Katz G, Urbach A et al. Characterization of the expression of MHC proteins in human embryonic stem cells. Proc Natl Acad Sci USA 2002;99:9864-9869.
4. Drukker M, Katchman H, Katz G et al. Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells. Stem Cells 2006;24:221-229.
5. Takahashi K, Tanabe K, Ohnuki M et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007;131:861-872.
6. Yu J, Vodyanik MA, Smuga-Otto K et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007;318:1917-1920.
7. Zhao T, Zhang ZN, Rong Z et al. Immunogenicity of induced pluripotent stem cells. Nature 2011;474:212-215.
8. Yoshida Y, Yamanaka S. Recent stem cell advances: Induced pluripotent stem cells for disease modeling and stem cell-based regeneration. Circulation 2010;122:80-87.
9. Pick M, Stelzer Y, Bar-Nur O et al. Clone- and gene-specific aberrations of parental imprinting in human induced pluripotent stem cells. Stem Cells 2009;27:2686-2690.
10. Schuldiner M, Yanuka O, Itskovitz-Eldor J et al. Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells. Proc Natl Acad Sci USA 2000;97:11307-11312.
11. Lowry WE, Richter L, Yachechko R et al. Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc Natl Acad Sci USA 2008;105:2883-2888.
12. Maherali N, Ahfeldt T, Rigamonti A et al. A high-efficiency system for the generation and study of human induced pluripotent stem cells. Cell Stem Cell 2008;3:340-345.
13. Masaki H, Ishikawa T, Takahashi S et al. Heterogeneity of pluripotent marker gene expression in colonies generated in human iPS cell induction culture. Stem Cell Res 2007;1:105-115.
14. Park IH, Zhao R, West JA et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 2008;451:141-146.
15. Mayshar Y, Ben-DaviD U, Lavon N et al. Identification and classification of chromosomal aberrations in multiple lines of human induced pluripotent stem cells. Cell Stem Cell 2010;7:521-531.
16. Luo RX, Postigo AA, Dean DC. Rb interacts with histone deacetylase to repress transcription. Cell 1998;92:463-473.
17. Menendez P, Bueno C, Wang L et al. Human embryonic stem cells: Potential tool for achieving immunotolerance? Stem Cell Rev 2005;1:151-158.
18. Gobin SJ, Biesta P, Van den Elsen PJ. Regulation of human beta 2-microglobulin transactivation in hematopoietic cells. Blood 2003;101:3058-3064.
19. Gobin SJ, van den Elsen PJ. The regulation of HLA class I expression: Is HLA-G the odd one out? Semin Cancer Biol 1999;9:55-59.
20. van den Elsen PJ, Holling TM, Kuipers HF et al. Transcriptional regulation of antigen presentation. Curr Opin Immunol 2004;16:67-75.
21. Rouas-Freiss N, Goncalves RM, Menier C et al. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci USA 1997;94:11520-11525.
22. Kovats S, Main EK, Librach C et al. A class I antigen, HLA-G, expressed in human trophoblasts. Science 1990;248:220-223.
23. Jurisicova A, Casper RF, MacLusky NJ et al. HLA-G expression during preimplantation human embryo development. Proc Natl Acad Sci USA 1996;93:161-165.
24. Desoye G, Dohr GA, Motter W et al. Lack of HLA class I and class II antigens on human preimplantation embryos. J Immunol 1988;140:4157-4159.
25. Robertson NJ, Brook FA, Gardner RL et al. Embryonic stem cellderived tissues are immunogenic but their inherent immune privilege promotes the induction of tolerance. Proc Natl Acad Sci USA 2007;104:20920-20925.
26. Swijnenburg RJ, Tanaka M, Vogel H et al. Embryonic stem cell immunogenicity increases upon differentiation after transplantation into ischemic myocardium. Circulation 2005;112:I166-172.
27. Kofidis T, deBruin JL, Tanaka M et al. They are not stealthy in the heart: Embryonic stem cells trigger cell infiltration, humoral and Tlymphocyte-based host immune response. Eur J Cardiothorac Surg 2005;28:461-466.
28. Bradley JA, Bolton EM, Pedersen RA. Stem cell medicine encounters the immune system. Nat Rev Immunol 2002;2:859-871.
29. Vallabhapurapu S, Karin M. Regulation and function of NF-kappaB transcription factors in the immune system. Annu Rev Immunol 2009;27:693-733.
30. Hayden MS, Ghosh S. Shared principles in NF-kappaB signaling. Cell 2008;132:344-362.
31. Gerondakis S, Grumont R, Gugasyan R et al. Unravelling the complexities of the NF-kappaB signalling pathway using mouse knockout and transgenic models. Oncogene 2006;25:6781-6799.
32. Beg AA, Sha WC, Bronson RT et al. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 1995;376:167-170.